Stocks and Investing Stocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022

Kevin Fischbeck Upgraded (ALHC) to Strong Buy and Decreased Target to $14 on, May 26th, 2022


Published on 2024-10-27 21:19:16 - WOPRAI, Kevin Fischbeck
  Print publication without navigation


Kevin Fischbeck of B of A Securities, Upgraded "Alignment Healthcare, Inc." (ALHC) to Strong Buy and Decreased Target from $18 to $14 on, May 26th, 2022.

Kevin has made no other calls on ALHC in the last 4 months.



There are 5 other peers that have a rating on ALHC. Out of the 5 peers that are also analyzing ALHC, 0 agree with Kevin's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Kevin


  • Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $14 on, Thursday, May 12th, 2022
  • Whit Mayo of "SVB Leerink" Initiated at Buy and Held Target at $19 on, Monday, April 4th, 2022
  • Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Decreased Target to $21 on, Monday, March 7th, 2022
  • Gary Taylor of "Cowen & Co." Maintained at Buy with Decreased Target to $11 on, Friday, March 4th, 2022
  • Jeff Garro of "Piper Sandler" Maintained at Buy with Decreased Target to $15 on, Thursday, February 24th, 2022
Contributing Sources